Go to main content
 
Replacement arrangements for anti-hypertensive drug Valtensin (with photos)
***************************************************************************
The following is issued on behalf of the Hospital Authority:

     The Hospital Authority (HA) spokesperson today (August 1) announced that in response to the earlier announcement by the Department of Health (DH) on the recall of the anti-hypertensive drug Valtensin (80mg tablets and 160mg tablets, containing the active drug ingredient valsartan) as it was found to contain an impurity, N-nitrosodimethylamine, an optional drug replacement will be offered to public hospital patients.
  
     Starting from this Saturday (August 4), the HA will arrange drug replacement counters at 18 designated public hospitals for two weeks for public hospital patients who had been dispensed with the drug Valtensin on or before July 6 to opt for replacement with alternative supply of valsartan tablets from other suppliers.
 
     The spokesperson pointed out that all public hospitals have already ceased to dispense the drug concerned, Valtensin (80 mg tablets and 160mg tablets), from July 6 in response to the DH recall. According to the assessment of clinical experts, there is no immediate risk to patients in continued intake of the drug. The experts are also of the view that an abrupt stop in taking the drug might cause an adverse effect on the patient's condition. Hence, patients who were dispensed with the drug are recommended to not stop taking it until they attend their next follow-up consultations, in which the patients would be prescribed the appropriate replacement medication after medical assessment.
 
     "The HA has recently secured adequate quantities of alternative supplies from overseas, which is sufficient to replace the quantities previously dispensed to patients. Therefore, patients can now opt for drug replacement before their next follow-up appointment," the spokesperson said.
     
     "Patients who choose to replace their drugs on hand should bring along their ID card with the drugs (see photos), or ask their delegate to bring along a copy of the patient's ID card and the drugs on hand, and go to any of the 18 designated counters as listed below during the period from August 4 to 17 for drug replacement after verification by the pharmacist on their respective dispensing records. No payment is required for the drug replacement."
 
     The spokesperson stressed that since the drug replacement service will last for two weeks from 9am to 9pm on a daily basis, patients can take their time to visit for drug replacement. Furthermore, patients who have their follow-up appointments at clinics in outlying islands will individually be notified on the drug replacement arrangements. The HA will also continue to closely liaise with the DH on the matter. 
 
     The 18 designated drug replacement counters are listed below:
 
Hospital Location of Drug Replacement Counter Enquiry Number
Pamela Youde Nethersole Eastern Hospital Main Pharmacy, Pamela Youde Nethersole Eastern Hospital 6460 0553
Ruttonjee Hospital Pharmacy, G/F, Admin Building, Ruttonjee Hospital 2291 2079
Queen Mary Hospital Central Pharmacy, 1/F, Block S, Queen Mary Hospital 2255 6649
Tung Wah Hospital Pharmacy, 1/F, Centenary Building, Tung Wah Hospital 2589 8111
Queen Elizabeth Hospital Pharmacy, 2/F, Ambulatory Care Centre, Queen Elizabeth Hospital 5278 2982
Kwong Wah Hospital Pharmacy, 1/F, North Wing,  Kwong Wah Hospital 3517 2700
Our Lady of Maryknoll Hospital Pharmacy, LG, Outpatient Block, Our Lady of Maryknoll Hospital 2354 0500
United Christian Hospital Pharmacy, G/F, Block S, United Christian Hospital 3949 4000
Tseung Kwan O Hospital Pharmacy, LG/F, Hospital Main Block, Tseung Kwan O Hospital 2208 0111
Princess Margaret Hospital Pharmacy, LG2, Block A, Princess Margaret Hospital 2370 0980
Caritas Medical Centre Pharmacy, LG1, Wai Ming Block, Caritas Medical Centre 3408 6348
North Lantau Hospital Pharmacy, 3/F,  North Lantau Hospital 3467 7340
Yan Chai Hospital Pharmacy, 1/F, Block C, Yan Chai Hospital 2417 8383
Prince of Wales Hospital Main Pharmacy, 1/F, Main Clinical Block and Trauma Centre, Prince of Wales Hospital 5569 9855
Alice Ho Miu Ling Nethersole Hospital Pharmacy, B1, Block C, Alice Ho Miu Ling Nethersole Hospital 2689 2699
North District Hospital Out-patient Pharmacy, North District Hospital 2683 7561
Tuen Mun Hospital Pharmacy, G/F, Ambulatory Care Centre, Tuen Mun Hospital (Saturday and Sunday)
Pharmacy, G/F, Main Block, Tuen Mun Hospital (Monday to Friday)
2468 6872
Pok Oi Hospital Pharmacy, M/F, Central Wing, Pok Oi Hospital 2401 4592
 
Drug replacement period: August 4 (Saturday) to August 17 (Friday)
Service hours: 9am to 9pm daily
 
Ends/Wednesday, August 1, 2018
Issued at HKT 19:28
NNNN
Today's Press Releases  

Photo

The Hospital Authority spokesperson today (August 1) announced that in response to the earlier announcement by the Department of Health on the recall of the anti-hypertensive drug Valtensin (80mg tablets and 160mg tablets, containing the active drug ingredient valsartan) as it was found to contain an impurity, N-nitrosodimethylamine, an optional drug replacement will be offered to public hospital patients. Photo shows Valtensin (80mg tablets).
The Hospital Authority spokesperson today (August 1) announced that in response to the earlier announcement by the Department of Health on the recall of the anti-hypertensive drug Valtensin (80mg tablets and 160mg tablets, containing the active drug ingredient valsartan) as it was found to contain an impurity, N-nitrosodimethylamine, an optional drug replacement will be offered to public hospital patients. Photo shows Valtensin (80mg tablets).
The Hospital Authority spokesperson today (August 1) announced that in response to the earlier announcement by the Department of Health on the recall of the anti-hypertensive drug Valtensin (80mg tablets and 160mg tablets, containing the active drug ingredient valsartan) as it was found to contain an impurity, N-nitrosodimethylamine, an optional drug replacement will be offered to public hospital patients. Photo shows Valtensin (160mg tablets).
The Hospital Authority spokesperson today (August 1) announced that in response to the earlier announcement by the Department of Health on the recall of the anti-hypertensive drug Valtensin (80mg tablets and 160mg tablets, containing the active drug ingredient valsartan) as it was found to contain an impurity, N-nitrosodimethylamine, an optional drug replacement will be offered to public hospital patients. Photo shows Valtensin (160mg tablets).